Followers | 15 |
Posts | 1915 |
Boards Moderated | 0 |
Alias Born | 09/27/2020 |
Wednesday, March 06, 2024 2:09:47 AM
The big question is... who will continue the manufacturing? Perhaps 3CL Pharma will take on the task. There were plans nearing completion where there would be multiple formulations of Tollovid available when the insolvency process began. I'd be happy with just the current formulation continuing to be manufactured. Tollovid has helped keep me Covid-free for the last 2.5 years when virtually everyone around me has contracted Covid at least once. It's not speculation when you understand the mechanism of viral replication and how Tollovid shuts it down. It works.
Only the ignorant would post about GC getting Covid once on his return flight from Israel, while omitting the fact that GC had extended his trip and didn't pack enough Tollovid, and wasn't taking it when he got infected. Or the fact that Tollovid is metabolized by the body at a rate that effectiveness wanes after 16-24 hours, which is why the maintenance dosing is 2 capsules/day, about 12 hours apart. Or the fact GC took the max dosing for 5 days upon his return and had no impact from the virus, and no need to consult multiple specialists. Those details fail to support the buffoon's narrative. LOL
Recent TOMDF News
- Form 15-12G - Securities registration termination [Section 12(g)] • Edgar (US Regulatory) • 07/17/2023 12:29:32 PM
Avant Technologies Engages Wired4Tech to Evaluate the Performance of Next Generation AI Server Technology • AVAI • May 23, 2024 8:00 AM
Branded Legacy, Inc. Unveils Collaboration with Celebrity Tattoo Artist Kat Tat for New Tattoo Aftercare Product • BLEG • May 22, 2024 8:30 AM
"Defo's Morning Briefing" Set to Debut for "GreenliteTV" • GRNL • May 21, 2024 2:28 PM
North Bay Resources Announces 50/50 JV at Fran Gold Project, British Columbia; Initiates NI 43-101 Resources Estimate and Bulk Sample • NBRI • May 21, 2024 9:07 AM
Greenlite Ventures Inks Deal to Acquire No Limit Technology • GRNL • May 17, 2024 3:00 PM
Music Licensing, Inc. (OTC: SONG) Subsidiary Pro Music Rights Secures Final Judgment of $114,081.30 USD, Demonstrating Strength of Licensing Agreements • SONGD • May 17, 2024 11:00 AM